Gynecological Endocrine Disorders, Psychological Support, Quality of Life, Risk Assessment, Targeted Nursing Care
Conditions
Brief summary
Risk-based targeted nursing significantly enhances clinical outcomes, quality of life, and mental health in patients with gynecological endocrine disorders, supporting its broader clinical application.
Detailed description
To evaluate the clinical value of targeted nursing care based on risk assessment in patients with gynecological endocrine disorders. A prospective controlled study was conducted to analyze the clinical data of 84 patients with endocrine disorders and 89 healthy women, focusing on identifying risk factors associated with endocrine disorders and designing corresponding personalized nursing interventions. A total of 154 patients with gynecological endocrine disorders, treated between December 2023 and June 2024, were randomly assigned into a control group (n = 77) and an observation group (n = 77) using a random number table method. The control group received routine nursing care, while the observation group received targeted nursing interventions based on risk assessment strategies in addition to routine care. Nursing outcomes, patient satisfaction, quality of life scores, and psychological status-including Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) scores-were compared between the two groups.
Interventions
Comprehensive Risk Assessment: Evaluation of lifestyle factors (diet, exercise, sleep), psychosocial stressors, medical history, and endocrine-specific biomarkers Personalized Care Plan: Tailored interventions addressing identified risk factors Psychological Component: Cognitive-behavioral techniques and stress management Lifestyle Modification: Guided nutrition (low-glycemic, high-fiber diet) and physical activity plans Reproductive Health Support: Menstrual cycle monitoring and fertility-related counseling
Sponsors
Study design
Eligibility
Inclusion criteria
Clinical diagnosis of gynecological endocrine disorder Aged 18-45 years Complete clinical data available Willing and able to provide informed consent
Exclusion criteria
Severe systemic or psychiatric illness Recent major surgery or hormonal/fertility treatment (within 3 months) Known hypersensitivity to study medications Currently pregnant or breastfeeding Participation in another clinical trial within 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Efficacy of Targeted Nursing in Gynecological Endocrine Disorders | Baseline to 6 months post-intervention. | Proportion of patients achieving significant improvement in endocrine symptoms (e.g., menstrual regularity, hormonal balance) post-intervention, assessed via physician evaluation and laboratory markers (e.g., LH/FSH ratio, testosterone levels). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Satisfaction with Nursing Care | End of intervention (Week 12). | Satisfaction rates measured via a 5-point Likert scale survey (1 = very dissatisfied to 5 = very satisfied), including domains of communication, pain management, and emotional support. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Adherence to Lifestyle Interventions | Weekly during intervention (Weeks 1-12). | Proportion of patients adhering to prescribed diet/exercise plans, recorded via self-reported logs and nurse audits. |
Countries
China